Top Markets
Coin of the day
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares

YD Bio Limited Ordinary Shares

YDES
Rangering i aksjer #19448
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company... Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Aksjekurs
$2.28
Sist synkronisert: 2026-07-31
Markedsverdi
$161.59M
Endring (1 dag)
3.70%
Endring (1 år)
-82.92%
Land
TW
Handel YD Bio Limited Ordinary Shares (YDES)

Kategori

Pris YDES pris med markedsverdi på B
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares
YDES
$2.28
Markedsverdi av YD Bio Limited Ordinary Shares(YDES)
Markedsverdi: $161.59M
Per August 2026 har YD Bio Limited Ordinary Shares en markedsverdi på $161.59M. Dette gjør YD Bio Limited Ordinary Shares til det 19448th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for YD Bio Limited Ordinary Shares fra 2025 til 2026
YDES sammenlignet med topp 5 mest populære stocks
Pris på YDES Eiendel B Markedsverdi for B Resultater
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares
$72,742.90 $161.59M
$5.152T +3,188,560.04%
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares
$64,053.74 $161.59M
$4.537T +2,807,673.50%
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares
$58,851.91 $161.59M
$4.169T +2,579,653.16%
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares
$51,422.76 $161.59M
$3.642T +2,253,999.20%
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares
$39,596.86 $161.59M
$2.805T +1,735,614.60%